KKR Korro Bio, Inc.
As of 3:59:00 PM ET · 11 h old· Couldn’t refresh just now; showing the last price
Loading chart…
- Open
- $97.93
- Previous close
- $98.01
- Day range
- 95.26 – 97.93
- 52-week range
- 82.67 – 144.84
- Volume
- 3.5M
- Avg volume (3M)
- 4.6M
- Market cap
- $88.7B
- P/E (TTM)
- 30.55
- EPS (TTM)
- $3.13
- Beta
- 1.72
- Dividend yield
- 0.79%
- Next earnings
- Nov 6, 2026(estimated from past report dates; not yet confirmed by the company)
- Ex-dividend
- Aug 10, 2026
- Sector
- Financial Services
About Korro Bio, Inc.
Korro Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-editing genetic medicines for rare and more common diseases. The company’s programs are designed to make precise changes at the RNA level, aiming to address disease-causing biology without permanently altering DNA. Its current pipeline includes lead candidate KRRO-121, a GalNAc-conjugated RNA editing oligonucleotide under development for hyperammonemia in patients with urea cycle disorders and hepatic encephalopathy, along with additional research programs in liver and other therapeutic areas. Korro Bio’s platform is built around programmable RNA editing and oligonucleotide-based delivery, positioning the company within the growing field of next-generation genetic medicines. Based in Cambridge, Massachusetts, Korro Bio focuses on discovery and development activities across its research and clinical-stage portfolio.
Next report: Fri, Nov 6, 2026(estimated from past report dates; not yet confirmed by the company)
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Jul 30, 2026(after close) | $1.43 | $1.63 | +14.0% |
| May 5, 2026(after close) | $1.26 | $1.39 | +10.3% |
| Feb 5, 2026(after close) | $1.14 | $1.12 | −1.8% |
| Nov 7, 2025(after close) | $1.30 | $1.41 | +8.5% |
| Jul 31, 2025(after close) | $1.14 | $1.18 | +3.5% |
- Annual dividend
- $0.76
- Yield
- 0.79%
- Frequency
- Quarterly
- Next ex-date
- —
| Ex-date | Amount |
|---|---|
| Aug 10, 2026 | $0.1950 |
| May 15, 2026 | $0.1950 |
| Feb 17, 2026 | $0.1850 |
| Nov 17, 2025 | $0.1850 |
| Aug 11, 2025 | $0.1850 |
| May 12, 2025 | $0.1850 |
| Feb 14, 2025 | $0.1750 |
| Nov 4, 2024 | $0.1750 |
| Aug 12, 2024 | $0.1750 |
| May 10, 2024 | $0.1750 |
| Feb 15, 2024 | $0.1650 |
| Nov 16, 2023 | $0.1650 |
| Aug 16, 2023 | $0.1650 |
| May 19, 2023 | $0.1650 |
| Feb 16, 2023 | $0.1550 |
| Nov 10, 2022 | $0.1550 |
KKR news and filings
Loading filings…
Filings from SEC EDGAR.